Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
718 Results for "
surface antigen
" in MedChemExpress (MCE) Product Catalog:
Products (718)
718 Results for "surface antigen" in MCE Product Catalog:
HBF-0259 is a potent and selective inhibitor of hepatitis B virus (HBV) surface antigen (HBsAg) secretion, with an EC50 of 1.5 μM in HepG2.2.15 cells. HBF-0259 has no effect on HBV DNA synthesis .
Cat. No.: HY-171181
CAS No.: 2306303-35-3
ZINC20451377 is a small molecule targeting hepatitis B (HBV) surface antigen (HBsAg) and can effectively inhibit wild-type hepatitis B and tenofovir (HY-13910)-resistant hepatitis B .
Cat. No.: HY-N15419
CAS No.: 18145-26-1
Target:
Cat. No.: HY-P2783
CAS No.: 79386-00-8
Category:
Target:
Cat. No.: HY-N2882
CAS No.: 133538-77-9
Target:
Cat. No.: HY-N12105
CAS No.: 1015175-06-0
Target:
Cat. No.: HY-W754691
CAS No.: 6808-72-6
Target:
Cat. No.: HY-173278
Target:
Research Areas:
AIC263282 is a potent Hepatitis B Virus (HBV) capsid assembly modulator with an EC50 of 3.8 nM. AIC263282 shows an IC50 of 61 nM for hERG. AIC263282 exhibits activity against viral replication and hepatitis B surface antigen (HBsAG) on primary human hepatocytes .
Cat. No.: HY-N3093
CAS No.: 1025023-05-5
Synonyms: (+)-Periglaucine B
Target:
Cat. No.: HY-145053A
CAS No.: 2716907-15-0
(5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). From patent WO2021204258A1, compound 6 .
Cat. No.: HY-145713
CAS No.: 2241575-59-5
Synonyms: HBV-IN-19
GS-8873 is an orally active inhibitor for the production of hepatitis B virus (HBV) surface antigen (HBsAg) with an EC50 of 4 nM. GS-8873 exhibits good pharmacokinetic characters in rats and metabolic stability in human hepatocytes. GS-8873 causes neurofunctional deficits in rats and cynomolgus monkeys .
Cat. No.: HY-N3094
CAS No.: 1025023-04-4
Cat. No.: HY-P4046
CAS No.: 337464-42-3
Target:
Research Areas:
Cat. No.: HY-157174
Target:
Research Areas:
Mannosamine-desthiobiotin adduct (compound MDTBA) is a carrier immunogenicity-reducing hapten that reduces the immunogenicity of protein carriers upon conjugation to available free amines on the carrier protein surface. Conjugation of Mannosamine-desthiobiotin adduct to hsIgG significantly (>1-fold) reduced the immunogenicity of hsIgG. Mannosamine-desthiobiotin adduct can be used in antigen design research .
Cat. No.: HY-107315
CAS No.: 443683-76-9
Cat. No.: HY-N12102
CAS No.: 1252572-36-3
Target:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
